"Lest we forget you--methylene blue...".
Neurobiol Aging
; 32(12): 2325.e7-16, 2011 Dec.
Article
en En
| MEDLINE
| ID: mdl-21316815
ABSTRACT
Methylene blue (MB), the first synthetic drug, has a 120-year-long history of diverse applications, both in medical treatments and as a staining reagent. In recent years there was a surge of interest in MB as an antimalarial agent and as a potential treatment of neurodegenerative disorders such as Alzheimer's disease (AD), possibly through its inhibition of the aggregation of tau protein. Here we review the history and medical applications of MB, with emphasis on recent developments.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Enfermedad de Alzheimer
/
Azul de Metileno
Tipo de estudio:
Diagnostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Neurobiol Aging
Año:
2011
Tipo del documento:
Article
País de afiliación:
Alemania